Importer of Controlled Substances Application: Pfizer Inc., 25705 [2023-08858]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 81 / Thursday, April 27, 2023 / Notices
non-approved finished dosage forms for
commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–08855 Filed 4–26–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
In
accordance with 21 CFR 1301.34(a), this
is notice that on March 16, 2023, Pfizer
Inc., 445 Eastern Point Road, Groton,
Connecticut 06340–5157, applied to be
registered as an importer of the
following basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug Enforcement Administration
[Docket No. DEA–1184]
Importer of Controlled Substances
Application: Pfizer Inc.
The company plans to import the
listed controlled substance as finished
dosage units for use in clinical trials. No
other activities for this drug code is
authorized for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
Pfizer Inc. has applied to be
registered as an importer of basic
class(es) of controlled substance(s).
Refer to SUPPLEMENTARY INFORMATION
listed below for further drug
information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before May 30, 2023. Such persons
may also file a written request for a
hearing on the application on or before
May 30, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUMMARY:
VerDate Sep<11>2014
17:49 Apr 26, 2023
Jkt 259001
2270
Schedule
Pentobarbital ................
AGENCY:
lotter on DSK11XQN23PROD with NOTICES1
Drug
code
[FR Doc. 2023–08858 Filed 4–26–23; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Notice of Lodging of Proposed
Consent Decree under the Clean Air
Act
On April 20, 2023 the Department of
Justice lodged a proposed consent
decree with the United States District
Court for the District of Utah in the
lawsuit entitled United States, State of
North Dakota, and State of Wyoming v.
MPLX, LP, Civil Action No. 2:23–cv–
00252–RJS.
The United States, State of North
Dakota and State of Wyoming filed this
lawsuit under the Clean Air Act. The
complaint alleges multiple violations of
the Leak Detection and Repair
provisions and other requirements in
the Clean Air Act’s New Source
Performance Standards and National
Emissions Standards for Hazardous Air
Pollutants. The consent decree will
require defendant to take specified
actions to come into compliance with
the Clean Air Act, pay a civil penalty of
$2 million, and take several pollution
mitigation actions to reduce volatile
organic compound emissions.
The publication of this notice opens
a period for public comment on the
proposed consent decree. Comments
should be addressed to the Assistant
Attorney General, Environment and
Frm 00089
Fmt 4703
Sfmt 4703
Natural Resources Division, and should
refer to United States, State of North
Dakota, and State of Wyoming v. MPLX,
LP, D.J. Ref. No. 90–5–2–1–11374/2. All
comments must be submitted no later
than thirty (30) days after the
publication date of this notice.
Comments may be submitted either by
email or by mail:
To submit
comments:
Send them to:
By email .......
pubcomment-ees.enrd@
usdoj.gov.
Assistant Attorney General,
U.S. DOJ—ENRD, P.O.
Box 7611, Washington, DC
20044–7611.
II
Matthew Strait,
Deputy Assistant Administrator.
PO 00000
25705
By mail .........
During the public comment period,
the proposed consent decree may be
examined and downloaded at this
Justice Department website: https://
www.justice.gov/enrd/consent-decrees.
We will provide a paper copy of the
proposed consent decree upon written
request and payment of reproduction
costs. Please mail your request and
payment to: Consent Decree Library,
U.S. DOJ—ENRD, P.O. Box 7611,
Washington, DC 20044–7611.
Please enclose a check or money order
for $41.00 (25 cents per page
reproduction cost) payable to the United
States Treasury.
Jeffrey Sands,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2023–08838 Filed 4–26–23; 8:45 am]
BILLING CODE 4410–15–P
DEPARTMENT OF JUSTICE
[OMB Number 1140–0070]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Revision of a
Previously Approved Collection
Application for Explosives License or
Permit—ATF Form 5400.13/5400.16
Bureau of Alcohol, Tobacco,
Firearms and Explosives, Department of
Justice.
AGENCY:
ACTION:
60-Day notice.
The Bureau of Alcohol,
Tobacco, Firearms and Explosives, U.S.
Department of Justice, is submitting the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995.
SUMMARY:
E:\FR\FM\27APN1.SGM
27APN1
]]>Agencies
[Federal Register Volume 88, Number 81 (Thursday, April 27, 2023)]
[Notices]
[Page 25705]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-08858]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1184]
Importer of Controlled Substances Application: Pfizer Inc.
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Pfizer Inc. has applied to be registered as an importer of
basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
May 30, 2023. Such persons may also file a written request for a
hearing on the application on or before May 30, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment. All
requests for a hearing must be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152. All requests for a hearing should also be
sent to: Drug Enforcement Administration, Attn: Administrator, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on March 16, 2023, Pfizer Inc., 445 Eastern Point Road,
Groton, Connecticut 06340-5157, applied to be registered as an importer
of the following basic class(es) of controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Pentobarbital.......................... 2270 II
------------------------------------------------------------------------
The company plans to import the listed controlled substance as
finished dosage units for use in clinical trials. No other activities
for this drug code is authorized for this registration.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-08858 Filed 4-26-23; 8:45 am]
BILLING CODE 4410-09-P
